OptimizeRx Corp., a provider of digital health messaging for the pharmaceutical industry, today announced it has acquired CareSpeak Communications, a provider of interactive health messaging for improved medication adherence and care coordination. For OptimizeRx, the acquisition addresses the critical industry need for direct communication between pharma and patients, supporting greater medication adherence, patient engagement, and health outcomesAs part of the acquisition, CareSpeak will
Read More
DexCom Integrates Continuous Glucose Monitoring Data with Validic Data Connectivity Platform
DexCom, Inc., a provider of continuous glucose monitoring (CGM) solutions, announced a partnership with data integration platform Validic. As part of the partnership, DexCom will integrate CGM data from Dexcom’s cloud API is integrated into the Validic’s connectivity platform to establish a multi-measure platform to stream in-home clinical data directly into clinical workflows and systems. This partnership is part of a larger effort to improve the interoperability of clinical systems and provide
Read More
HealthXCapital Launches $25M Early-Stage Digital Health VC Fund in SE Asia and India
Singapore-based venture capital firm HealthXCapital today announced the launch of its US$25 million digital health venture capital (VC) fund focused on emerging markets in South East Asia and India. The fund was backed by Apollo Hospitals, Jungle Ventures, Eight Roads Ventures (the proprietary investment arm of Fidelity International Limited), and other undisclosed private investors.HealthXCapital will focus on addressing: Access & Affordability — by investing in innovative healthcare
Read More
Health2047 Spin Out Launches with $2M to Build Platform for People Living with Prediabetes
Health2047 Inc., an American Medical Association-backed company that develops and commercializes solutions to transform healthcare at the system level, today announced the spin out of First Mile Care. With $2M in seed funding, First Mile Care is a preventive chronic care startup that is building an affordable, scalable and sustainable platform to improve the lives of people who have prediabetes. Development is already underway for First Mile Care’s initial platform offering is based on the
Read More
Modis Therapeutics Raises $30M for Developing Medicines for Patients with Rare Genetic Diseases
Modis Therapeutics, Inc., a company developing medicines for patients with rare genetic diseases has raised $30 million in Series A funding led by F-Prime Capital Partners and OrbiMed. Joshua Grass, former F-Prime Entrepreneur-in-Residence and head of Corporate Development at BioMarin Pharmaceutical, has joined as President and Chief Executive Officer. Founding investor Aceras Life Sciences, LLC and new investor Osage University Partners also participated in the financing.Founded in 2016, Modis
Read More
Biotech Startup Akrevia Therapeutics Lands $30M to Develop Next-Gen Cancer Immunotherapies
Akrevia Therapeutic, a Cambridge, MA-based biotech startup focused on developing highly-potent, tumor-targeted immuno-oncology therapeutics has raised $30 million in funding led by F-Prime Capital Partners and Atlas Venture. The funding will be used to accelerate Akrevia's pipeline and proprietary Aklusion® platform, which allows therapeutic antibodies, cytokines and chemokines to be specifically activated in the tumor microenvironment and tailored with precisely optimized pharmacologic
Read More
Novo Nordisk Launches the Innovation Challenge Focused on Diabetes Management
Novo Nordisk, a global leader in the diabetes space, is seizing the opportunity to advance care and leverage digital health technology through the Novo Nordisk Innovation Challenge. With support from MATTER, a prominent incubator and innovation hub, Novo Nordisk is challenging start-ups, researchers, entrepreneurs, and students to explore, design; and co-develop digital health solutions for the more than 400 million people living with diabetes worldwide.The first phase of the challenge is
Read More
Proscia Raises $8M for AI-Enhanced Digital Pathology for Cancer Diagnosis
Proscia, a Philadelphia-based digital pathology platform has raised $8.3 million in Series A funding led by Boston-based Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures, and RobinHood Ventures.The startup plans to utilize the Series A funding to fuel the development and commercialization of new, clinical AI-enabled workflows targeting high-volume, high-impact cancers, the first of which will be available later this year. In
Read More
VRHealth, Oculus Team Up to Power Virtual Reality Wellness Solutions for Patients
VRHealth, a Boston, MA-based healthcare technology company providing specialized virtual reality (VR) technology solutions and data analysis, today announced that they are teaming up with Oculus to deliver their newest health and wellness solutions using Oculus products. Virtual Reality solutions have the potential to be transformative for the healthcare industry since the immersive experience and ability to monitor progress has enormous potential benefits for patients, doctors, and healthcare
Read More
AI Diagnostics Startup IDx Nabs $33M for Autonomous Detection of Diabetic Retinopath
IDx, a Coralville, Iowa-based startup that developed the first and only FDA-cleared autonomous AI diagnostic systems, has raised $33 million in funding led by 8VC with participation from Optum Ventures, Alpha Edison and Heritage Provider Network. This latest round of funding will accelerate the adoption of IDx-DR and allow IDx to continue developing additional AI-based diagnostic systems.Founded in 2010 by a team of clinical scientists, IDx is focused on developing clinically-aligned autonomous
Read More